郑州郑州近视手术医院排名(郑州郑州哪家医院激光科好) (今日更新中)

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

The Pentagon is slashing .8 billion in recently passed military funding to finance construction of the president's long-sought U.S.-Mexico border wall. Thursday's move by the Pentagon angered not just Democrats but also GOP defense hawks. It would cut money for National Guard units, shipbuilding accounts and 17 aircraft and transfer it to anti-drug accounts that can finance construction of new wall. The maneuver was announced in “reprogramming” documents provided to lawmakers and came in for harsh criticism by Rep. Mack Thornberry of Texas, the top Republican on the House Armed Services Committee. Democrats slammed the transfers as well, but Trump faced no consequences when making similar transfers last year. 732

The week-long freefall for the Dow Jones Industrial Average continued in trading Friday, ending the most tumultuous week the index has had in nearly 12 years. The Dow sank by 1,000 points during trading Friday, as the market continues to fear that the COVID-19 outbreak will result in a worldwide economic slowdown.Stocks recovered by the end of the day, but ended the day down about 350 points.The Dow 415

The Trump administration told Congress it intends to dramatically cut the number of refugees it will admit in the next fiscal year, only up to 18,000 refugees, according to the State Department -- marking a historic low and threatening to further erode the nation's refugee resettlement program.Under President Donald Trump, the administration has slowly chipped away at the refugee cap, which dictates how many refugees may be admitted to the United States. The ceiling for fiscal year 2019 stands at 30,000, which, at the time, was the lowest level since 1980.The State Department announced the proposed refugee ceiling as part of a larger number of combined refugee and asylum claims expected for the next fiscal year.In a call with reporters, senior administration officials said the report submitted to Congress allocates admissions by "group of special humanitarian interests to the United States," instead of by region -- including Iraqis who assisted the United States, those who have suffered or feared religious persecution, and nationals of Guatemala, Honduras and El Salvador.The White House also released an executive order Thursday that requires state and local governments to consent to receiving refugees, with some exceptions. Refugee resettlement agencies are charged with placing refugees around the country, but the new executive order could allow states and local jurisdictions to deny refugees entry.The move continues the administration's push to limit the number of people admitted to the US and comes after discussion that some in the White House wanted to let 1597

The US economy grew at an annual rate of 2.1% in the second quarter, the Commerce Department announced Friday.That's better than economists had expected, but slower than the 3.1% pace 196

来源：资阳报